hVIVO making four poster presentations at ISIRV AVG 2018, Washington, D.C. USA, Nov 2018

6th Advances in Respiratory Virus Therapeutics, 13 November – 15 November 2018

hVIVO will be making four scientific poster presentations at the ISIRV AVG 2018 conference in Washington, DC USA, 2018.

• Topic: “Human viral challenge model: A systematic analysis of placebo population data from six RSV studies.”
  Nicolas Noulin, Associate Director, Scientific Operations, hVIVO
• Topic: “Use of qualitative integrated Cycler PCR to trigger therapeutic/placebo dosing in human experimental infection: a retrospective analysis.”
  Nicolas Noulin, Associate Director, Scientific Operations, hVIVO
• Topic: “The utilisation of enhanced assay strategies for the RSV human challenge model.”
  Brandon Löndt, Development Operations Manager
• Topic:  “The RSV Human Viral Challenge Model: Over a decade of experience, what next?”
  Rob Lambkin-Williams, Executive Scientific Advisor, hVIVO

hVIVO’s Scientific and Operations Director, and Senior Director Business Development, will both be available for meetings at the congress.

If you would like to schedule a meeting with hVIVO at ISIRV AVG 2018, contact us.